ADP and Thromboxane Inhibitors Both Reduce Global Contraction of Clot Length, While Thromboxane Inhibition Attenuates Internal Aggregate Contraction.

TH Open · 2022 · PMC9192180 · PMID 35707619

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

noticeably significantno p-value reported

Some ADP and/or TXA2 conditions showed marginally higher % contraction than control, but there did not appear to be a noticeably significant trend.

also in 63 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.